By ANDY OBER Assistant Managing Editor InsideIndianaBusiness INDIANAPOLIS — The U.S. Food and Drug Administration has approved a type 2 diabetes treatment from Indianapolis-based Eli Lilly and Co. and Boehringer Ingelheim Pharmaceuticals Inc. Synjardy was also approved earlier this year by the European Medicines Agency. Lilly says Synjardy is the third product containing the medicine epagliflozin to …read more.